The deal will help patients in new markets to receive Car T-cell therapy.
Christopher Luxon says global hyperscaler complained to him about the cost of building data centres here relative to Australia.
The move was at the request of shareholders following a special resolution.
The startup will use the funds to get US regulatory approval for its arterial coupler.
The Government proposed to ban the machines last month because of concerns about their use in money laundering.
Its magnesium can be used to make exotic alloys used in the transportation, aviation, and aerospace sectors.
Second-time founders Shaun Quincey and Damon O’Neill are now servicing more than 250,000 life insurance policies on their platform.
Tertiary Extracts Ōtautahi is raising funds to ramp up US sales.
The landscape for climate-tech companies has changed dramatically.
The Auckland University spin-out is raising money on Catalist ahead of an $8m to $10m Series A round early next year.